Prescription opioids for back pain and use of medications for erectile dysfunction. (1/11)

Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder. (2/11)

Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. (3/11)

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. (4/11)

Thymosin beta4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. (5/11)

Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a meta-analysis. (6/11)

Comparative, prospective, and randomized study between urotherapy and the pharmacological treatment of children with urinary incontinence. (7/11)

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial. (8/11)

• 1
• 2